Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) CFO Benjamin Hohl Sells 6,018 Shares

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) CFO Benjamin Hohl sold 6,018 shares of the business’s stock in a transaction dated Wednesday, June 17th. The shares were sold at an average price of $43.80, for a total value of $263,588.40. Following the completion of the transaction, the chief financial officer owned 51,000 shares in the company, valued at $2,233,800. The trade was a 10.55% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bitwise MARA Option Income Strategy ETF Price Performance

IMRA stock opened at $17.64 on Tuesday. The business has a 50 day simple moving average of $16.56 and a two-hundred day simple moving average of $15.79. Bitwise MARA Option Income Strategy ETF has a 1-year low of $11.99 and a 1-year high of $54.94. The company has a market capitalization of $3.35 million, a price-to-earnings ratio of 352.80 and a beta of 2.88.

Bitwise MARA Option Income Strategy ETF Company Profile

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.